(Q40410604)

English

Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa

scientific article published on January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa (English)

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

acute pyelonephritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

Evangelos J Giamarellos-Bourboulis

1

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Helen Giamarellou

9

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

author name string

Theodoros Adamis

2

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

George Laoutaris

3

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Lambros Sabracos

4

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Vassilios Koussoulas

5

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Maria Mouktaroudi

6

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Despina Perrea

7

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Panayotis E Karayannacos

8

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

48

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

1

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

93-99

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

22 September 2017

Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

22 September 2017

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

22 September 2017

Anti-inflammatory effects of macrolide antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

22 September 2017

Immunological therapy of sepsis: experimental therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

22 September 2017

Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

22 September 2017

Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

22 September 2017

Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

22 September 2017

The epidemiology of bacterial sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

22 September 2017

Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

25 September 2017

Anti-inflammatory activity of macrolide antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

25 September 2017

Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

15 June 2018

Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

20 August 2018

Macrolide-treated Pseudomonas aeruginosa induces paradoxical host responses in the lungs of mice and a high mortality rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

20 August 2018

Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

20 August 2018

In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

20 August 2018

Clarithromycin attenuates the inflammatory response induced by surgical trauma in a guinea pig model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

20 August 2018

Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310186

20 August 2018

Comparative efficacy of gemifloxacin in experimental models of pyelonephritis and wound infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/14693524

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/14693524

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cytokine responses in acute Escherichia coli pyelonephritis in IL-6-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/14693524

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/14693524

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response

1 reference

https://pubmed.ncbi.nlm.nih.gov/14693524

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/14693524

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation

1 reference

https://pubmed.ncbi.nlm.nih.gov/14693524

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/14693524

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-dependent inhibition of cell proliferation induced by lipid peroxidation products in rat hepatoma cells after enrichment with arachidonic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/14693524

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.48.1.93-99.2004

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

release_uvjol5bf3naw3chbuukglalpbm

1 reference

https://api.fatcat.wiki/v0/release/uvjol5bf3naw3chbuukglalpbm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40410604&oldid=1897117325"